retatrutide type 2 diabetes phase 2 trial results Lilly's triple agonist delivers up to 71.2 lbs of weight loss Lilly's triple agonist achieves 16.8%

Weight loss goals are now disease-driven, not cosmetic 5% minimum meaningful benefit 10% required for most metabolic conditions 15% often needed for OSA, HFpEF, MASH, and severe obesity Medication choice is guided by comorbidities GLP-1 receptor agonists and dual GIP/GLP-1 agents are prioritized in patients with: Prediabetes & type 2 diabetes ASCVD Heart failure with preserved EF Metabolic liver disease Obstructive sleep apnea Cardiovascular outcomes now matter Semaglutide 2.4 mg demonstrated a significant reduction in major cardiovascular events even in people without diabetes

Glow is a targeted probiotic and prebiotic formula designed to support gut balance, digestive health, and overall wellness

PlexusDx connects patients with telehealth providers who prescribe compounded GLP-1 medications for weight loss without insurance requirements

Discover how to effectively incorporate GLP-1 medications into your lifestyle with Dole's expert tips on nutrition, exercise, and healthy habits for weight management.

Ideal for those seeking a natural way to feel more in control of their appetite and wellness goals, LifeSeasons GLP-1 Support is non-GMO, vegetarian, and crafted with premium ingredients you can trust

All patches are free of Artificial Dyes, Casein, Corn, Colors, Dairy, Egg, Fillers, Flavorings, Gluten, GMOs, Latex, MSG, Peanuts, Preservatives, Shellfish, Soy, Sugar, Tree Nuts and Wheat